Clinical outcomes of Targeted Homeopathic Protocols and Bowel Nosodes in Irritable Bowel Syndrome (IBS): A Retrospective Observational Case Series from Bangladesh

Abstract

Background: Irritable Bowel Syndrome (IBS) is a prevalent functional gastrointestinal disorder characterized by abdominal pain, altered bowel habits, bloating, and food intolerances, significantly impairing quality of life. Conventional management primarily offers transient symptomatic relief. Targeted homeopathic protocols and bowel nosodes present a potential noninvasive, structured therapeutic option. This retrospective case series evaluates the clinical symptom resolution and dietary tolerance recovery in patients with IBS undergoing a combined homeopathic protocol alongside dietary advice. Methods: A retrospective analysis was conducted on 30 patients presenting with IBS-M (Mixed) and IBS-D (Diarrhea-predominant with dysenteric features) diagnosed per Rome IV criteria. Symptoms included frequent evacuation (3–4 times daily), incomplete clearance, mucus-laden stools, dairy/lipid intolerances, and concurrent gastritis. Patients were evaluated over a 3-month period receiving a paired remedy protocol (Mercurius vivus 200C, Chelidonium majus 30C, Mercurius solubilis 6C, Ipecacuanha 30C, Dysentery Compound 30C, and Nux Vomica 30C) alongside a structured 4-week initial trigger food avoidance (Low-FODMAP guidance) followed by gradual reintroduction. Results: High rates of clinical symptom resolution were observed across all 30 patients within the 12-week timeframe. Stool frequency normalized to 1–2 evacuations daily, rectal tenesmus resolved, and epigastric discomfort was alleviated. Furthermore, oral tolerance to previously restricted foods (milk, fatty meals, leafy greens) was successfully restored without reported adverse events. Conclusion: The observational findings suggest that structured homeopathic protocols paired with bowel nosodes and lifestyle/dietary guidance may serve as a beneficial adjunct management strategy in IBS. Given the retrospective and uncontrolled design, prospective randomized controlled trials (RCTs) are warranted to evaluate causality and long-term efficacy.